Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000071.xml
Semin Neurol 2019; 39(03): 369-382
DOI: 10.1055/s-0039-1687837
DOI: 10.1055/s-0039-1687837
Review Article
Herpesvirus Infections of the Central Nervous System
Further Information
Publication History
Publication Date:
02 August 2019 (online)
![](https://www.thieme-connect.de/media/sin/201903/lookinside/thumbnails/10-1055-s-0039-1687837_180092-1.jpg)
Abstract
There are over 200 herpesvirus species, of which 10 affect humans. Each of these 10 herpesviruses has a unique clinical syndrome, but common to all is their ability to cause infection and pathology in the central nervous system. In this article, we discuss the epidemiology, clinical presentation, diagnostic modalities, treatment, sequelae, and availability of vaccination of each of the following herpesviruses: herpes simplex virus 1 and 2, varicella zoster virus, human cytomegalovirus, human herpesvirus 6A, 6B, and 7, Epstein–Barr virus, human herpesvirus 8, and simian herpesvirus B.
* Joint first authors.
-
References
- 1 Knipe DM, Howley P. Fields Virology. Philadelphia, PA: Wolters Kluwer Health; 2013
- 2 Scheld WM, Whitley RJ, Marra CM. Infections of the Central Nervous System. Philadelphia, PA: Wolters Kluwer Health; 2014
- 3 Dimmock NJ, Easton AJ, Leppard KN. Introduction to Modern Virology. Hoboken, NJ: Wiley Blackwell; 2016
- 4 Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychol Rehabil 2007; 17 (4–5): 406-428
- 5 Boucher A, Herrmann JL, Morand P. , et al. Epidemiology of infectious encephalitis causes in 2016. Med Mal Infect 2017; 47 (03) 221-235
- 6 Solomon T, Michael BD, Smith PE. , et al; National Encephalitis Guidelines Development and Stakeholder Groups Management of suspected viral encephalitis in adults–Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012; 64 (04) 347-373
- 7 Venkatesan A, Tunkel AR, Bloch KC. , et al; International Encephalitis Consortium Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57 (08) 1114-1128
- 8 Dowdle WR, Nahmias AJ, Harwell RW, Pauls FP. Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol 1967; 99 (05) 974-980
- 9 Looker KJ, Magaret AS, May MT. , et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One 2015; 10 (10) e0140765
- 10 Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186 (Suppl. 01) S3-S28
- 11 Whitley RJ, Kimberlin DW. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 2005; 16 (01) 17-23
- 12 Thellman NM, Triezenberg SJ. Herpes simplex virus establishment, maintenance, and reactivation: in vitro modeling of latency. Pathogens 2017; 6 (03) 28
- 13 Saylor D, Thakur K, Venkatesan A. Acute encephalitis in the immunocompromised individual. Curr Opin Infect Dis 2015; 28 (04) 330-336
- 14 Fine AJ, Sorbello A, Kortepeter C, Scarazzini L. Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients. Clin Infect Dis 2013; 57 (06) 849-852
- 15 Bradford RD, Pettit AC, Wright PW. , et al. Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis 2009; 49 (06) 924-927
- 16 Kenney AD, Dowdle JA, Bozzacco L. , et al. Human genetic determinants of viral diseases. Annu Rev Genet 2017; 51 (01) 241-263
- 17 Moraru M, Cisneros E, Gómez-Lozano N. , et al. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J Immunol 2012; 188 (09) 4412-4420
- 18 Mancini M, Vidal SM. Insights into the pathogenesis of herpes simplex encephalitis from mouse models. Mamm Genome 2018; 29 (7–8): 425-445
- 19 Bowen CD, Paavilainen H, Renner DW. , et al. HSV-1 strains circulating in Finland demonstrate uncoupling of geographic and phenotypic variation. bioRxiv 2018 . Available at: https://www.biorxiv.org/content/10.1101/424408v1 . Accessed March 28, 2019
- 20 Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006; 71 (2–3): 141-148
- 21 Hart RP, Kwentus JA, Frazier RB, Hormel TL. Natural history of Klüver-Bucy syndrome after treated herpes encephalitis. South Med J 1986; 79 (11) 1376-1378
- 22 Fisher CM. Hypomanic symptoms caused by herpes simplex encephalitis. Neurology 1996; 47 (06) 1374-1378
- 23 Livorsi D, Anderson E, Qureshi S, Howard M, Wang YF, Franco-Paredes C. Brainstem encephalitis: an unusual presentation of herpes simplex virus infection. J Neurol 2010; 257 (09) 1432-1437
- 24 McGill F, Griffiths MJ, Bonnett LJ. , et al; UK Meningitis Study Investigators Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis 2018; 18 (09) 992-1003
- 25 Figueroa D, Isache C, Sands M, Guzman N. An unusual case of acute transverse myelitis caused by HSV-1 infection. IDCases 2016; 5: 29-31
- 26 Nakajima H, Furutama D, Kimura F. , et al. Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol 1998; 39 (03) 163-167
- 27 Azuma K, Yoshimoto M, Nishimura Y. , et al. Herpes simplex virus type 1 myelitis with a favorable outcome. Intern Med 2001; 40 (10) 1068-1069
- 28 Perlejewski K, Popiel M, Laskus T. , et al. Next-generation sequencing (NGS) in the identification of encephalitis-causing viruses: Unexpected detection of human herpesvirus 1 while searching for RNA pathogens. J Virol Methods 2015; 226: 1-6
- 29 Fang X, Xu M, Fang Q. , et al. Real-time utilization of metagenomic sequencing in the diagnosis and treatment monitoring of an invasive adenovirus B55 infection and subsequent herpes simplex virus encephalitis in an immunocompetent young adult. Open Forum Infect Dis 2018; 5 (06) ofy114
- 30 Granerod J, Davies NWS, Mukonoweshuro W. , et al; UK Public Health England Aetiology of Encephalitis Study Group Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement. Clin Radiol 2016; 71 (10) 1050-1058
- 31 Soares BP, Provenzale JM. Imaging of herpesvirus infections of the CNS. AJR Am J Roentgenol 2016; 206 (01) 39-48
- 32 Gnann Jr JW, Sköldenberg B, Hart J. , et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy. Clin Infect Dis 2015; 61 (05) 683-691
- 33 Gnann Jr JW, Whitley RJ. Herpes simplex encephalitis: an update. Curr Infect Dis Rep 2017; 19 (03) 13
- 34 Crumpacker CS. Ganciclovir. N Engl J Med 1996; 335 (10) 721-729
- 35 Zhu XP, Muhammad ZS, Wang JG, Lin W, Guo SK, Zhang W. HSV-2 vaccine: current status and insight into factors for developing an efficient vaccine. Viruses 2014; 6 (02) 371-390
- 36 Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One 2015; 10 (01) e114989
- 37 Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008; 65 (05) 596-600
- 38 Johnston C, Magaret A, Roychoudhury P. , et al. Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: a nested cross-sectional viral genotyping study. PLoS Med 2017; 14 (12) e1002475
- 39 Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 2003; 77 (18) 10168-10171
- 40 Lee AJ, Chen B, Chew MV. , et al. Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection. J Exp Med 2017; 214 (04) 1153-1167
- 41 Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes. Infection 2016; 44 (03) 337-345
- 42 Corral I, Quereda C, Navas E, Pérez-Elias MJ, Jover F, Moreno S. Sacral myeloradiculitis complicating genital herpes in a HIV-infected patient. Int J STD AIDS 2005; 16 (02) 175-177
- 43 Momméja-Marin H, Lafaurie M, Scieux C, Galicier L, Oksenhendler E, Molina JM. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis 2003; 37 (11) 1527-1533
- 44 Landry ML. Frequency of normal cerebrospinal fluid protein level and leukocyte count in enterovirus meningitis. J Clin Virol 2005; 32 (01) 73-74
- 45 O'Sullivan CE, Aksamit AJ, Harrington JR, Harmsen WS, Mitchell PS, Patel R. Clinical spectrum and laboratory characteristics associated with detection of herpes simplex virus DNA in cerebrospinal fluid. Mayo Clin Proc 2003; 78 (11) 1347-1352
- 46 Fernandez-Gerlinger M, Greffe S, Meffre A. , et al. HSV-2 meningoencephalitis in an immunocompetent young man: what is the pathogenesis and what is the treatment?. J Clin Virol 2015; 69: 40-43
- 47 Zis P, Stritsou P, Angelidakis P, Tavernarakis A. Herpes simplex virus type 2 encephalitis as a cause of ischemic stroke: case report and systematic review of the literature. J Stroke Cerebrovasc Dis 2016; 25 (02) 335-339
- 48 Harrison NA, MacDonald BK, Scott G, Kapoor R. Atypical herpes type 2 encephalitis associated with normal MRI imaging. J Neurol Neurosurg Psychiatry 2003; 74 (07) 974-976
- 49 Heininger U, Seward JF. Varicella. Lancet 2006; 368 (9544) 1365-1376
- 50 Chapman RS, Cross KW, Fleming DM. The incidence of shingles and its implications for vaccination policy. Vaccine 2003; 21 (19–20): 2541-2547
- 51 Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005; 20 (08) 748-753
- 52 Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol 2010; 48 (Suppl. 01) S2-S7
- 53 Ogunjimi B, Zhang SY, Sørensen KB. , et al. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest 2017; 127 (09) 3543-3556
- 54 Grahn A, Studahl M. Varicella-zoster virus infections of the central nervous system – prognosis, diagnostics and treatment. J Infect 2015; 71 (03) 281-293
- 55 Alves CAPF, Fragoso DC, Gonçalves FG, Marussi VH, Amaral LLFD. Cerebellar ataxia in children: a clinical and MRI approach to the differential diagnosis. Top Magn Reson Imaging 2018; 27 (04) 275-302
- 56 Thomas SL, Minassian C, Ganesan V, Langan SM, Smeeth L. Chickenpox and risk of stroke: a self-controlled case series analysis. Clin Infect Dis 2014; 58 (01) 61-68
- 57 Depledge DP, Cudini J, Kundu S. , et al. High viral diversity and mixed infections in cerebral spinal fluid from cases of varicella zoster virus encephalitis. J Infect Dis 2018; 218 (10) 1592-1601
- 58 Kost RG, Straus SE. Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med 1996; 335 (01) 32-42
- 59 Steiner I, Kennedy PGE, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007; 6 (11) 1015-1028
- 60 Marra F, Ruckenstein J, Richardson K. A meta-analysis of stroke risk following herpes zoster infection. BMC Infect Dis 2017; 17 (01) 198
- 61 Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009; 8 (08) 731-740
- 62 Cresswell F, Eadie J, Longley N, Macallan D. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis 2010; 14 (02) e161-e163
- 63 Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991; 37 (07) 1153-1160
- 64 Baldwin KJ, Cummings CL. Herpesvirus infections of the nervous system. Continuum (Minneap Minn) 2018; 24 (5, Neuroinfectious Disease): 1349-1369
- 65 Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2014; (02) CD006866
- 66 Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 2016; 16 (12) 789-802
- 67 Tselis AC. Epstein-Barr virus infections of the nervous system. In: Tselis AC, Booss J. , eds. Handbook of Clinical Neurology: Neurovirology, Vol. 123. Amsterdam: Elsevier; 2014: 285-305
- 68 Fujimoto H, Asaoka K, Imaizumi T, Ayabe M, Shoji H, Kaji M. Epstein-Barr virus infections of the central nervous system. Intern Med 2003; 42 (01) 33-40
- 69 Kennard C, Swash M. Acute viral encephalitis: its diagnosis and outcome. Brain 1981; 104 (Pt 1): 129-148
- 70 Domachowske JB, Cunningham CK, Cummings DL, Crosley CJ, Hannan WP, Weiner LB. Acute manifestations and neurologic sequelae of Epstein-Barr virus encephalitis in children. Pediatr Infect Dis J 1996; 15 (10) 871-875
- 71 Sworn MJ, Urich H. Acute encephalitis in infectious mononucleosis. J Pathol 1970; 100 (03) 201-205
- 72 Torre D, Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis 1999; 31 (06) 543-547
- 73 Wu M, Huang F, Jiang X. , et al. Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation. PLoS One 2013; 8 (10) e77805-e77805
- 74 Bower M, Palfreeman A, Alfa-Wali M. , et al; British HIV Association British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med 2014; 15 (Suppl. 02) 1-92
- 75 Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol 2013; 9 (06) 317-327
- 76 Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17 (05) 355-363
- 77 Kalayjian RC, Cohen ML, Bonomo RA, Flanigan TP. Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features. Medicine (Baltimore) 1993; 72 (02) 67-77
- 78 Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes 2004; 11 (Suppl. 02) 95A-104A
- 79 Griffiths PD. Do opportunistic viruses hunt in packs?. Rev Med Virol 2018; 28 (03) e1982
- 80 Seok JH, Ahn K, Park HJ. Diffusion MRI findings of cytomegalovirus-associated ventriculitis: a case report. Br J Radiol 2011; 84 (1005) e179-e181
- 81 Rubin DI. NeuroImages. “Owl's eyes” of CMV ventriculitis. Neurology 2000; 54 (12) 2217
- 82 Hassine D, Gray F, Chekroun R, De Truchis P, Schouman-Claeys E, Vallée C. CMV and VZV encephalitis in AIDS [in French]. J Neuroradiol 1995; 22 (03) 184-192
- 83 Renard T, Daumas-Duport B, Auffray-Calvier E, Bourcier R, Desal H. Cytomegalovirus encephalitis: undescribed diffusion-weighted imaging characteristics. Original aspects of cases extracted from a retrospective study, and from literature review. J Neuroradiol 2016; 43 (06) 371-377
- 84 Chemaly RF, Chou S, Einsele H. , et al; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials. Clin Infect Dis 2018 (e-pub ahead of print). doi:10.1093/cid/ciy696
- 85 Tanasescu R, Evangelou N, Constantinescu CS. Role of oral teriflunomide in the management of multiple sclerosis. Neuropsychiatr Dis Treat 2013; 9: 539-553
- 86 Upadhyayula S, Michaels MG. Ganciclovir, foscarnet, and cidofovir: antiviral drugs not just for cytomegalovirus. J Pediatric Infect Dis Soc 2013; 2 (03) 286-290
- 87 Kronfli N, Haider S. Management of cytomegalovirus in hematopoietic stem cell transplant recipients: a review of novel pharmacologic and cellular therapies. Off J Assoc Med Microbiol Infect Dis Can. 2017; 2 (01) 32-40
- 88 Schmidt-Hieber M, Silling G, Schalk E. , et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 2016; 27 (07) 1207-1225
- 89 Marty FM, Ljungman P, Chemaly RF. , et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med 2017; 377 (25) 2433-2444
- 90 Griffiths PD. Cytomegalovirus vaccine: timing is important. Rev Med Virol 2018; 28 (04) e1986
- 91 Salahuddin SZ, Ablashi DV, Markham PD. , et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234 (4776) 596-601
- 92 Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev 2015; 28 (02) 313-335
- 93 Ward KN. Child and adult forms of human herpesvirus 6 encephalitis: looking back, looking forward. Curr Opin Neurol 2014; 27 (03) 349-355
- 94 Green DA, Pereira M, Miko B, Radmard S, Whittier S, Thakur K. Clinical significance of human herpesvirus 6 positivity on the filmarray meningitis/encephalitis panel. Clin Infect Dis 2018; 67 (07) 1125-1128
- 95 Bates M, Monze M, Bima H. , et al. Predominant human herpesvirus 6 variant A infant infections in an HIV-1 endemic region of Sub-Saharan Africa. J Med Virol 2009; 81 (05) 779-789
- 96 Sharp C, Golubchik T, Gregory WF. , et al. Human herpes virus 6 (HHV-6) - pathogen or passenger? A pilot study of clinical laboratory data and next generation sequencing. bioRxiv 2018 . Available at: https://www.biorxiv.org/content/10.1101/236083v4 . Accessed March 28, 2019
- 97 Clark DA. Clinical and laboratory features of human herpesvirus 6 chromosomal integration. Clin Microbiol Infect 2016; 22 (04) 333-339
- 98 Yoshikawa T, Ohashi M, Miyake F. , et al. Exanthem subitum-associated encephalitis: nationwide survey in Japan. Pediatr Neurol 2009; 41 (05) 353-358
- 99 Whitley RJ, Lakeman FD. Human herpesvirus 6 infection of the central nervous system: is it just a case of mistaken association?. Clin Infect Dis 2005; 40 (06) 894-895
- 100 Gorniak RJ, Young GS, Wiese DE, Marty FM, Schwartz RB. MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation. AJNR Am J Neuroradiol 2006; 27 (04) 887-891
- 101 Provenzale JM, vanLandingham KE, Lewis DV, Mukundan Jr S, White LE. Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging. Radiology 2008; 249 (03) 955-963
- 102 Colombier MA, Amorim S, Salmona M, Thieblemont C, Legoff J, Lafaurie M. HHV-6 reactivation as a cause of fever in autologous hematopoietic stem cell transplant recipients. J Infect 2017; 75 (02) 155-159
- 103 Ljungman P, de la Camara R, Cordonnier C. , et al; European Conference on Infections in Leukemia Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42 (04) 227-240
- 104 Ablashi DV, Berneman ZN, Kramarsky B, Whitman Jr J, Asano Y, Pearson GR. Human herpesvirus-7 (HHV-7): current status. Clin Diagn Virol 1995; 4 (01) 1-13
- 105 Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol 1999; 9 (04) 245-262
- 106 Schwartz KL, Richardson SE, Ward KN. , et al. Delayed primary HHV-7 infection and neurologic disease. Pediatrics 2014; 133 (06) e1541-e1547
- 107 Parra M, Alcala A, Amoros C. , et al. Encephalitis associated with human herpesvirus-7 infection in an immunocompetent adult. Virol J 2017; 14 (01) 97-97
- 108 Chan PK, Ng HK, Cheung JL, Ng KC, Cheng AF. Prevalence and distribution of human herpesvirus 7 in normal brain. J Med Virol 2000; 62 (03) 345-348
- 109 Riva N, Franconi I, Meschiari M. , et al. Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature. Infection 2017; 45 (03) 385-388
- 110 Chang Y, Cesarman E, Pessin MS. , et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266 (5192) 1865-1869
- 111 Regamey N, Tamm M, Wernli M. , et al. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339 (19) 1358-1363
- 112 Pawar RV, Fatterpekar GM, Zagzag D, Parker EC, Narayana A. Multicentric Castleman's disease of the central nervous system : evaluation with dynamic susceptibility contrast perfusion magnetic resonance imaging. Clin Neuroradiol 2012; 22 (03) 245-251
- 113 Baldini F, Baiocchini A, Schininà V. , et al. Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy. BMC Infect Dis 2013; 13 (01) 600-600
- 114 Sabin AB, Wright AM. Acute ascending myelitis following a monkey bite, with the isolation of a virus capable of reproducing the disease. J Exp Med 1934; 59 (02) 115-136
- 115 Weigler BJ, Roberts JA, Hird DW, Lerche NW, Hilliard JK. A cross sectional survey for B virus antibody in a colony of group housed rhesus macaques. Lab Anim Sci 1990; 40 (03) 257-261
- 116 CDC. B Virus (herpes B, monkey B virus, herpesvirus simiae, and herpesvirus B). Available at: https://www.cdc.gov/herpesbvirus/index.html . 2014. Accessed September 22, 2018
- 117 Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE. ; B Virus Working Group Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis 2002; 35 (10) 1191-1203